Nanobodies—miniature proteins—derived from camel antibodies demonstrated powerful potential to accurately and safely deliver radioisotopes as specialized cancer treatments in a project at ORNL.

This article explores how advanced immune imaging technologies enable real-time visualization of immune responses, improving ...

This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...

CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

Christopher H. Contag explores how tissue regeneration involves organized interactions beyond just cell replacement, highlighting two emerging technologies ...

The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, which has invested heavily in cell and gene therapy technology.

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

How does a tiny cluster of cells become an embryo with a head, trunk, and tail? And how do thousands of genes coordinate this development? A new imaging method makes it possible to visualize the ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to ...

Researchers create a massive single-cell atlas of the aging mouse brain, revealing how epigenetic changes and "jumping genes" drive neurodegeneration.

The iGE3 Genomics Platform provides access to the state-of-the-art methods in genomic technologies. Our platform provides a seamless, end-to-end solution tailored to your research needs. From ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...